Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

Name: Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
Published: 2024
License: Public Domain

Centre Jean Perrin · 2024

ClinicalTrials.gov · Datasets · License: Public Domain · 2024

Open Source ↗

biomarkers lu na prediction response

castration-resistant metastatic prostate cancer, treated by 177lutetium-psma-617 (lu-psma), mcrpc, lu-psma, biomarkers, response, prediction, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

Related documents